138 related articles for article (PubMed ID: 9069099)
1. Biomarkers in hydrolysed urine, plasma and erythrocytes among workers exposed to thermal degradation products from toluene diisocyanate foam.
Lind P; Dalene M; Tinnerberg H; Skarping G
Analyst; 1997 Jan; 122(1):51-6. PubMed ID: 9069099
[TBL] [Abstract][Full Text] [Related]
2. Biological monitoring of occupational exposure to toluene diisocyanate: measurement of toluenediamine in hydrolysed urine and plasma by gas chromatography-mass spectrometry.
Persson P; Dalene M; Skarping G; Adamsson M; Hagmar L
Br J Ind Med; 1993 Dec; 50(12):1111-8. PubMed ID: 8280642
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6- toluene diisocyanate.
Lind P; Dalene M; Skarping G; Hagmar L
Occup Environ Med; 1996 Feb; 53(2):94-9. PubMed ID: 8777457
[TBL] [Abstract][Full Text] [Related]
4. Workers exposed to thermal degradation products of TDI- and MDI-based polyurethane: biomonitoring of 2,4-TDA, 2,6-TDA, and 4,4'-MDA in hydrolyzed urine and plasma.
Dalene M; Skarping G; Lind P
Am Ind Hyg Assoc J; 1997 Aug; 58(8):587-91. PubMed ID: 9248033
[TBL] [Abstract][Full Text] [Related]
5. Air and biological monitoring of toluene diisocyanate in a flexible foam plant.
Tinnerberg H; Dalene M; Skarping G
Am Ind Hyg Assoc J; 1997 Mar; 58(3):229-35. PubMed ID: 9075314
[TBL] [Abstract][Full Text] [Related]
6. Exposure to 2,4- and 2,6-toluene diisocyanate (TDI) during production of flexible foam: determination of airborne TDI and urinary 2,4- and 2,6-toluenediamine (TDA).
Kääriä K; Hirvonen A; Norppa H; Piirilä P; Vainio H; Rosenberg C
Analyst; 2001 Jul; 126(7):1025-31. PubMed ID: 11478630
[TBL] [Abstract][Full Text] [Related]
7. Air exposure assessment of TDI and biological monitoring of TDA in urine in workers in polyurethane foam industry.
Geens T; Dugardin S; Schockaert A; De Cooman G; van Sprundel M
Occup Environ Med; 2012 Feb; 69(2):93-8. PubMed ID: 21725071
[TBL] [Abstract][Full Text] [Related]
8. Biological monitoring as a valid tool to assess occupational exposure to mixtures of 2,4-:2,6-toluene diisocyanate.
De Palma G; Cortesi I; Ghitti R; Festa D; Bergonzi R; Apostoli P
Med Lav; 2012; 103(5):361-71. PubMed ID: 23077796
[TBL] [Abstract][Full Text] [Related]
9. Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate.
Skarping G; Brorson T; Sangö C
Int Arch Occup Environ Health; 1991; 63(2):83-8. PubMed ID: 1653771
[TBL] [Abstract][Full Text] [Related]
10. Improvement in the GC-MS method for determining urinary toluene-diamine and its application to the biological monitoring of workers exposed to toluene-diisocyanate.
Sakai T; Morita Y; Roh J; Kim H; Kim Y
Int Arch Occup Environ Health; 2005 Jul; 78(6):459-66. PubMed ID: 15918038
[TBL] [Abstract][Full Text] [Related]
11. Albumin adducts in plasma from workers exposed to toluene diisocyanate.
Lind P; Dalene M; Lindström V; Grubb A; Skarping G
Analyst; 1997 Feb; 122(2):151-4. PubMed ID: 9124697
[TBL] [Abstract][Full Text] [Related]
12. Biological monitoring of isocyanates and related amines. IV. 2,4- and 2,6-toluenediamine in hydrolysed plasma and urine after test-chamber exposure of humans to 2,4- and 2,6-toluene diisocyanate.
Brorson T; Skarping G; Sangö C
Int Arch Occup Environ Health; 1991; 63(4):253-9. PubMed ID: 1660449
[TBL] [Abstract][Full Text] [Related]
13. Determination of toluenediamine isomers by capillary gas chromatography and chemical ionization mass spectrometry with special reference to the biological monitoring of 2,4- and 2,6-toluene diisocyanate.
Skarping G; Dalene M; Lind P
J Chromatogr A; 1994 Mar; 663(2):199-210. PubMed ID: 8173666
[TBL] [Abstract][Full Text] [Related]
14. Exposure to toluenediamines from polyurethane-covered breast implants.
Sepai O; Henschler D; Czech S; Eckert P; Sabbioni G
Toxicol Lett; 1995 May; 77(1-3):371-8. PubMed ID: 7618164
[TBL] [Abstract][Full Text] [Related]
15. Protein adducts as biomarkers of exposure to aromatic diisocyanates in workers manufacturing polyurethane (PUR) foam.
Säkkinen K; Tornaeus J; Hesso A; Hirvonen A; Vainio H; Norppa H; Rosenberg C
J Environ Monit; 2011 Apr; 13(4):957-65. PubMed ID: 21344094
[TBL] [Abstract][Full Text] [Related]
16. Biological monitoring of aromatic diisocyanates in workers exposed to thermal degradation products of polyurethanes.
Rosenberg C; Nikkilä K; Henriks-Eckerman ML; Peltonen K; Engströrm K
J Environ Monit; 2002 Oct; 4(5):711-6. PubMed ID: 12400919
[TBL] [Abstract][Full Text] [Related]
17. The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate.
Broberg KE; Warholm M; Tinnerberg H; Axmon A; Jönsson BA; Sennbro CJ; Littorin M; Rannug A
Pharmacogenet Genomics; 2010 Feb; 20(2):104-11. PubMed ID: 20032816
[TBL] [Abstract][Full Text] [Related]
18. LC-MS determination of urinary toluenediamine in workers exposed to toluenediisocyanate.
Sakai T; Morita Y; Kim Y; Tao YX
Toxicol Lett; 2002 Aug; 134(1-3):259-64. PubMed ID: 12191886
[TBL] [Abstract][Full Text] [Related]
19. Risk evaluation of occupational exposure to methylene dianiline and toluene diamine in polyurethane foam.
Lewandowski TA; Hayes AW; Beck BD
Hum Exp Toxicol; 2005 Dec; 24(12):655-62. PubMed ID: 16408619
[TBL] [Abstract][Full Text] [Related]
20. Degradation of polyurethane foams used in the Même breast implant.
Benoit FM
J Biomed Mater Res; 1993 Oct; 27(10):1341-8. PubMed ID: 8245048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
